"Thromboplastin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation.
| Descriptor ID |
D013925
|
| MeSH Number(s) |
D12.776.124.125.900 D23.119.965
|
| Concept/Terms |
Thromboplastin- Thromboplastin
- Coagulin
- Factor III
- Glomerular Procoagulant Activity
- Activity, Glomerular Procoagulant
- Procoagulant Activity, Glomerular
- Prothrombinase
- CD142 Antigens
- Tissue Factor Procoagulant
- Procoagulant, Tissue Factor
- Tissue Thromboplastin
- Thromboplastin, Tissue
- Urothromboplastin
- Blood Coagulation Factor III
- Antigens, CD142
- Coagulation Factor III
- Factor III, Coagulation
- Tissue Factor
|
Below are MeSH descriptors whose meaning is more general than "Thromboplastin".
Below are MeSH descriptors whose meaning is more specific than "Thromboplastin".
This graph shows the total number of publications written about "Thromboplastin" by people in this website by year, and whether "Thromboplastin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thromboplastin" by people in Profiles.
-
Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD. J Am Soc Nephrol. 2021 11; 32(11):2834-2850.
-
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2021 05; 22(5):609-619.
-
Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts. Sci Rep. 2020 02 06; 10(1):2005.
-
The AHR: adaptive evolution or one-off? Blood. 2019 12 26; 134(26):2337-2338.
-
Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. Blood. 2019 12 26; 134(26):2399-2413.
-
Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis. Arthritis Res Ther. 2019 07 18; 21(1):176.
-
Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans. J Am Soc Nephrol. 2018 03; 29(3):1063-1072.
-
Subarachnoid hemorrhage - Induced block of cerebrospinal fluid flow: Role of brain coagulation factor III (tissue factor). J Cereb Blood Flow Metab. 2018 05; 38(5):793-808.
-
Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature. J Thromb Haemost. 2017 03; 15(3):526-537.
-
THE ENDOTHELIUM IN SEPSIS. Shock. 2016 Mar; 45(3):259-70.